Johnson & Johnson (Singapore)

Recent papers from Johnson & Johnson (Singapore)

1. Economic evaluation of Impella versus VA-ECMO in acute myocardial infarction cardiogenic shockEuropean Heart Journal · 2026
2. Warm autoimmune haemolytic anaemia in Taiwan: A population‐based study of epidemiology, treatment patterns, survival and healthcare utilisation (2017–2022)British Journal of Haematology · 2026
3. Radical Prostatectomy and Perioperative Hormonal Therapy in High-Risk Localized Prostate Cancer Asian PatientsProstate International · 2026
4. Efficacy and Safety of Teclistamab in Relapsed/Refractory Multiple Myeloma: 2‐Year Follow‐Up From MajesTEC‐1 China CohorteJHaem · 2026
5. Efficacy and safety of ustekinumab in Asian patients with moderately to severely active Crohn’s disease: a small subpopulation analysis of UNITI/IM-UNITI long-term extension through 5 yearsIntestinal Research · 2026
6. New Tuberculosis Infection and Reactivation of Tuberculosis in Patients with Psoriasis or Psoriatic Arthritis Receiving IL-23 Inhibitors: A Systematic Literature ReviewDermatology and Therapy · 2026
7. Cost-Effectiveness of Impella Versus Veno-Arterial Extracorporeal Membrane Oxygenation in Patients With Acute Myocardial Infarction Cardiogenic ShockHeart Lung and Circulation · 2026
8. Guselkumab efficacy and safety in East Asian participants with moderately to severely active Crohn’s disease: subgroup analysis of the phase 3 GALAXI 2 and GALAXI 3 trialsIntestinal Research · 2026
9. Surgical site infection following caesarean section: Incidence and healthcare resource utilisation in a tertiary mother and children hospital in MalaysiaInfection Disease & Health · 2026
10. Niraparib With Abiraterone Acetate Plus Prednisone as First‐Line Therapy in Patients With Metastatic Castration‐Resistant Prostate Cancer With Homologous Recombination Repair Gene Alterations: Final Analysis of the Asian Subgroup From the MAGNITUDE StudyInternational Journal of Urology · 2026
11. Patient- and Caregiver-Reported Burden and Quality of Life in Generalised Myasthenia Gravis: A Multinational Real-World Survey in the Asia–Pacific RegionNeurology and Therapy · 2026
12. Asia-Pacific practical consensus in the management of adverse events related to amivantamab-based therapies in non-small cell lung cancerLung Cancer · 2026
13. Focusing on color: How the eye chooses which wavelength to see bestScience Advances · 2026
14. Clinical Evaluation of Toric Soft Lens ReproducibilityOptometry and Vision Science · 2002
15. Real-World Study Assessing the Efficacy and Safety of a Novel KLEx Procedure with a Next-Generation Femtosecond Laser for Refractive Error CorrectionClinical ophthalmology · 2026
16. Evaluation of PSA decline patterns in the Chinese subgroup of LIBERTAS, a phase 3 study of apalutamide plus continuous versus intermittent androgen deprivation therapy in metastatic castration-sensitive prostate cancer.Journal of Clinical Oncology · 2026
17. Efficacy and safety of subcutaneous guselkumab in East Asian participants with moderately to severely active Crohn’s disease: subgroup analysis of the Phase 3 GRAVITI studyIntestinal Research · 2026
18. Persistence and Long-Term Disease Control of Interleukin-17 Inhibitors and Interleukin-23 Inhibitors in Patients with Psoriasis: A Nationwide Cohort Study in JapanPsoriasis Targets and Therapy · 2026
19. OP10Symptomatic improvement with intravenous guselkumab induction therapy is observed early in patients with moderately to severely active Ulcerative Colitis: post-hoc analysis of QUASARJournal of Crohn s and Colitis · 2026
20. Persistence of interleukin-17 and interleukin-23 inhibitors in patients with plaque psoriasis: a real-world study in TaiwanJournal of Dermatological Treatment · 2026